IL-7 Reporter HEK 293 Cells
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
HEK-Blue™ IL-7 Cells HEK 293 reporter cells for human and murine IL-7 cytokines |
Show product |
3-7 x 10e6 cells |
hkb-il7
|
|
||
HEK-Blue™ IL-7 vial Additional cell vial |
Show product |
3-7 x 10e6 cells |
hkb-il7-av
|
Notification: Reference #hkb-il7-av can only be ordered together with reference #hkb-il7.
Interleukin-7 Reporter Cells
Signaling pathway in HEK-Blue™ IL-7 cells
HEK-Blue™ IL-7 cells were engineered from the human embryonic kidney HEK 293 cell line to detect bioactive interleukin-7 (IL-7) by monitoring the activation of the JAK/STAT5 pathway. They can also be used for screening antibodies or small molecule inhibitors targeting the IL-7 pathway.
IL-7 is a secreted cytokine that plays an essential role in B cell and T cell development and function [1-4].
Cell line description
HEK-Blue™ IL-7 cells were generated by stable transfection with the genes encoding the human IL-7 receptor (IL-7Rα and IL-2Rγ chains), human JAK3, human STAT5b, and a STAT5-inducible secreted embryonic alkaline phosphatase (SEAP) reporter. The binding of IL-7 to its receptor triggers a signaling cascade leading to the activation of STAT5 and the subsequent production of SEAP. This can be readily assessed in the supernatant using QUANTI-Blue™ Solution, a SEAP detection reagent.
HEK-Blue™ IL-7 cells detect human and murine IL-7 (see figures). Of note, HEK‑Blue™ IL-7 cells also exhibit a moderate response to human IFN-γ but do not respond to human IFN-α (see figures).
Key features
- Fully functional IL-7 signaling pathway
- Readily assessable STAT5-inducible SEAP reporter activity
- Strong response to human (h) and mouse (m) IL-7
Applications
- Detection and quantification of hIL-7 and mIL-7 activity
- Screening of anti-IL-7 and anti-IL-7 receptor antibodies
- Screening of small molecule inhibitors of the IL-7 pathway
References:
1. Lin J. et al., 2017. The role of IL-7 in Immunity and Cancer. Anticancer Res. 37(3):963-7.
2. Ribeir D. et al., 2018. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. Blood Adv. 2(17):2199-213.
3. Mackall C.L. et al., 2011. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 11(5):330-42.
4. Barata J.T. et al., 2019. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 20(12):1584-93.
Specifications
Antibiotic resistance: Blasticidin, Hygromycin B, Puromycin, Zeocin®
Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin®
Specificity: Detects human IL-7 and mouse IL-7
Detection range:
- Detection range for human IL-7: 100 pg/ml - 100 ng/ml
- Detection range for murine IL-7: 100 pg/ml - 100 ng/ml
Quality Control:
- SEAP reporter activity in response to IL-7 is validated using functional assays.
- The stability for 20 passages following thawing is confirmed.
- These cells are tested for mycoplasma contamination.
This product is covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 1 vial containing 3-7 x 106 cells
- 2 x 1 ml HEK-Blue™ Selection (250X concentrate)
- 1 ml of Puromycin (10 mg/ml)
- 1 ml Normocin® (50 mg/ml)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA, Canada and some areas in Asia)
Back to the topDetails
Interleukin 7 (IL-7) is a secreted cytokine that plays an essential role in B cell and T cell development and function [1]. IL-7 signals through the heterodimeric cell surface IL-7 receptor (IL-7R) consisting of IL-7Rα (also called CD127) and IL-2Rγ (also called the common γ-chain or CD132).
The binding of IL-7 to its receptor triggers three main signaling pathways: JAK/STAT, PI3K, and MAPK/ERK [1‑3]. Of note, IL-7R-mediated signaling triggers proliferative and anti‑apoptotic signals mainly by activating the JAK/STAT pathway [1-3]. IL-7/IL-7R signaling, which regulates lymphocyte growth and survival, has been implicated in the development of malignancies and autoimmune diseases [1-4].
1. Lin J. et al., 2017. The role of IL-7 in Immunity and Cancer. Anticancer Res. 37(3):963-7.
2. Ribeir D. et al., 2018. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. Blood Adv. 2(17):2199-213.
3. Mackall C.L. et al., 2011. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 11(5):330-42.
4. Barata J.T. et al., 2019. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 20(12):1584-93.